Literature DB >> 4567547

Lithium and chlorpromazine: a controlled crossover study of hyperactive severely disturbed young children.

M Campbell, B Fish, J Korein, T Shapiro, P Collins, C Koh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4567547     DOI: 10.1007/bf01537617

Source DB:  PubMed          Journal:  J Autism Child Schizophr        ISSN: 0021-9185


× No keyword cloud information.
  40 in total

1.  [Result of lithium carbonate therapy of the agitation states].

Authors:  M E VARTANIAN
Journal:  Zh Nevropatol Psikhiatr Im S S Korsakova       Date:  1959

2.  Evaluation of lithium in treatment of psychotic excitement.

Authors:  B GLESINGER
Journal:  Med J Aust       Date:  1954-02-20       Impact factor: 7.738

3.  Lithium salts in the treatment of psychotic excitement.

Authors:  J F J CADE
Journal:  Med J Aust       Date:  1949-09-03       Impact factor: 7.738

4.  Manic-depressive illness in children and effect of treatment with lithium carbonate.

Authors:  A L Annell
Journal:  Acta Paedopsychiatr       Date:  1969

5.  Lithium and leukocytosis.

Authors:  B Shopsin; R Friedmann; S Gershon
Journal:  Clin Pharmacol Ther       Date:  1971 Nov-Dec       Impact factor: 6.875

6.  Long-term prognosis and the response of schizophrenic children to drug therapy: a controlled study of trifluoperazine.

Authors:  B Fish; T Shapiro; M Campbell
Journal:  Am J Psychiatry       Date:  1966-07       Impact factor: 18.112

7.  Increased blood serotonin and platelets in early infantile autism.

Authors:  E R Ritvo; A Yuwiler; E Geller; E M Ornitz; K Saeger; S Plotkin
Journal:  Arch Gen Psychiatry       Date:  1970-12

8.  Stimulation of serotonin synthesis by lithium.

Authors:  J Perez-Cruet; A Tagliamonte; P Tagliamonte; G L Gessa
Journal:  J Pharmacol Exp Ther       Date:  1971-08       Impact factor: 4.030

9.  Comparison of trifluperidol, trifluoperazine and chlorpromazine in preschool schizophrenic children: the value of less sedative antipsychotic agents.

Authors:  B Fish; M Campbell; T Shapiro; A Floyd
Journal:  Curr Ther Res Clin Exp       Date:  1969-10

10.  Childhood schizophrenia; clinical study on one hundred schizophrenic children.

Authors:  L BENDER
Journal:  Am J Orthopsychiatry       Date:  1947-01
View more
  9 in total

Review 1.  Therapeutics of aggression in children.

Authors:  D S Pine; E Cohen
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

Review 2.  Pharmacological treatment of mood disturbances, aggression, and self-injury in persons with pervasive developmental disorders.

Authors:  B H King
Journal:  J Autism Dev Disord       Date:  2000-10

3.  Response to triiodothyronine and dextroamphetamine: a study of preschool schizophrenic children.

Authors:  M Campbell; B Fish; R David; T Shapiro; P Collins; C Koh
Journal:  J Autism Child Schizophr       Date:  1972 Oct-Dec

Review 4.  Management options for bipolar disorder in children and adolescents.

Authors:  Arman Danielyan; Robert A Kowatch
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 5.  Pharmacological treatment of self-injurious behavior in mentally retarded persons.

Authors:  N N Singh; C J Millichamp
Journal:  J Autism Dev Disord       Date:  1985-09

6.  A controlled crossover study of triiodothyronine in autistic children.

Authors:  M Campbell; A M Small; C S Hollander; J Korein; I L Cohen; M Kalmijn; S Ferris
Journal:  J Autism Child Schizophr       Date:  1978-12

7.  Catatonia in autistic disorder: a sign of comorbidity or variable expression?

Authors:  G M Realmuto; G J August
Journal:  J Autism Dev Disord       Date:  1991-12

Review 8.  Lithium for schizophrenia.

Authors:  Stefan Leucht; Bartosz Helfer; Markus Dold; Werner Kissling; John J McGrath
Journal:  Cochrane Database Syst Rev       Date:  2015-10-28

Review 9.  Aggression in autism spectrum disorder: presentation and treatment options.

Authors:  Sarah E Fitzpatrick; Laura Srivorakiat; Logan K Wink; Ernest V Pedapati; Craig A Erickson
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-23       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.